AMPK promotes survival and adipogenesis of ischemia-challenged ADSCs in an autophagy-dependent manner

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Dec;1863(12):1498-1510. doi: 10.1016/j.bbalip.2018.10.002. Epub 2018 Oct 6.

Abstract

Some studies have shown that transplanted fat tissues usually cannot survive for long if adipose-derived stem cells (ADSCs) are removed from the tissues in advance. It is more meaningful to explore the mechanism mediating survival and differentiation of ADSCs in the transplanted microenvironment. AMP-activated protein kinase (AMPK) has been shown to be one of the energy receptors that regulate many aspects of cellular metabolism. AMPK activation has been implicated in models of adult ischemic injury, but the mechanism and the regulating effects of AMPK on survival and adipogenesis of transplanted ADSCs are still little known. In this study, we simulated the transplanted microenvironment using oxygen-glucose deprivation (OGD) to test the survival and adipogenesis of ADSCs. We found that OGD treatment triggered significant apoptosis and promoted autophagy. Simultaneously, OGD hindered the differentiation of ADSCs into mature adipocytes. After inhibiting AMPK, the OGD-induced apoptosis rate increased but autophagy was inhibited. The adipogenesis level also decreased. To show that the effects of AMPK on apoptosis and adipogenesis were autophagy-dependent, we pre-inhibited or pre-promoted autophagy with siATG7 or rapamycin while blocking AMPK. We found that inhibiting or improving autophagy exacerbated or alleviated the role of AMPK prohibition in apoptosis and adipogenesis. Furthermore, we showed that AMPK inhibition significantly lowered ULK1 activity but promoted mTOR activity, so that to inhibit autophagy. Our study shows that AMPK plays a protective role in maintaining survival and adipogenesis of OGD-challenged ADSCs partly by positively regulating autophagy. AMPK positively regulates autophagy by inhibiting mTOR but promoting ULK1 activity in OGD condition.

Keywords: AMP-activated protein kinase; Adipogenesis; Adipose-derived stem cells; Autophagy; Ischemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Adipogenesis*
  • Adipose Tissue / cytology*
  • Adipose Tissue / metabolism
  • Autophagy* / drug effects
  • Autophagy-Related Protein 7 / antagonists & inhibitors
  • Autophagy-Related Protein-1 Homolog / metabolism
  • Cell Differentiation
  • Cell Hypoxia
  • Cell Survival
  • Cells, Cultured
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism
  • RNA, Small Interfering / pharmacology
  • Sirolimus / pharmacology
  • Stem Cells / cytology
  • Stem Cells / metabolism
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Intracellular Signaling Peptides and Proteins
  • RNA, Small Interfering
  • MTOR protein, human
  • Autophagy-Related Protein-1 Homolog
  • TOR Serine-Threonine Kinases
  • ULK1 protein, human
  • AMP-Activated Protein Kinases
  • ATG7 protein, human
  • Autophagy-Related Protein 7
  • Sirolimus